Literature DB >> 21866178

Mortality amenable to health care in the United States: the roles of demographics and health systems performance.

Stephen C Schoenbaum1, Cathy Schoen, Jennifer L Nicholson, Joel C Cantor.   

Abstract

This article examines associations of socio-demographic and health-care indicators, and the statistic 'mortality amenable to health care' (amenable mortality) across the US states. There is over two-fold variation in amenable mortality, strongly associated with the percentages of state populations that are poor or black. Controlling for poverty and race with bi- and multi-variate analyses, several indicators of health system performance, such as hospital readmission rates and preventive care for diabetics, are significantly associated with amenable mortality. A significant crude association of 'uninsurance' and amenable mortality rates is no longer statistically significant when poverty and race are controlled. Overall, there appear to be opportunities for states to focus on specific modifiable health system performance indicators. Comparative rates of amenable mortality should be useful for estimating potential gains in population health from delivering more timely and effective care and for tracking the health outcomes of efforts to improve health system performance.

Entities:  

Mesh:

Year:  2011        PMID: 21866178     DOI: 10.1057/jphp.2011.42

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  17 in total

1.  Untimely applause was a distraction. Comment on "Shanghai rising: health improvements as measured by avoidable mortality since 2000".

Authors:  Fei Yan; Jian Zhang
Journal:  Int J Health Policy Manag       Date:  2015-03-13

2.  Shanghai rising: health improvements as measured by avoidable mortality since 2000.

Authors:  Michael K Gusmano; Victor G Rodwin; Chunfang Wang; Daniel Weisz; Li Luo; Fu Hua
Journal:  Int J Health Policy Manag       Date:  2014-12-27

3.  Commentary: approaches, strengths, and limitations of avoidable mortality.

Authors:  Glòria Pérez; Maica Rodríguez-Sanz; Eva Cirera; Katherine Pérez; Rosa Puigpinós; Carme Borrell
Journal:  J Public Health Policy       Date:  2014-03-13       Impact factor: 2.222

4.  Risk factors for 30-day readmissions after hepatectomy: analysis of 2444 patients from the ACS-NSQIP database.

Authors:  Sooyeon Kim; Erin C Maynard; Malay B Shah; Michael F Daily; Ching-Wei D Tzeng; Daniel L Davenport; Roberto Gedaly
Journal:  J Gastrointest Surg       Date:  2014-12-02       Impact factor: 3.452

5.  Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation.

Authors:  David J Taber; Arun P Palanisamy; Titte R Srinivas; Mulugeta Gebregziabher; John Odeghe; Kenneth D Chavin; Leonard E Egede; Prabhakar K Baliga
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

6.  The Contribution of Health Care and Other Interventions to Black-White Disparities in Life Expectancy, 1980-2007.

Authors:  Irma T Elo; Hiram Beltrán-Sánchez; James Macinko
Journal:  Popul Res Policy Rev       Date:  2014-02-01

7.  County Health Factors Associated with Avoidable Deaths from Cardiovascular Disease in the United States, 2006-2010.

Authors:  Sophia Greer; Linda J Schieb; Matthew Ritchey; Mary George; Michele Casper
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

8.  Social capital's impact on COVID-19 outcomes at local levels.

Authors:  Timothy Fraser; Courtney Page-Tan; Daniel P Aldrich
Journal:  Sci Rep       Date:  2022-04-21       Impact factor: 4.996

9.  The contribution of health policy and care to income differences in life expectancy--a register based cohort study.

Authors:  Kristiina Manderbacka; Riina Peltonen; Sonja Lumme; Ilmo Keskimäki; Lasse Tarkiainen; Pekka Martikainen
Journal:  BMC Public Health       Date:  2013-09-08       Impact factor: 3.295

10.  Trends in socioeconomic inequalities in amenable mortality in urban areas of Spanish cities, 1996-2007.

Authors:  Andreu Nolasco; José Antonio Quesada; Joaquín Moncho; Inmaculada Melchor; Pamela Pereyra-Zamora; Nayara Tamayo-Fonseca; Miguel Angel Martínez-Beneito; Oscar Zurriaga
Journal:  BMC Public Health       Date:  2014-04-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.